The GLOW Blend combines GHK-Cu, BPC-157, and TB-500 in a single vial, bringing together copper-binding, gut-related, and recovery-focused research peptides for researchers across Australia studying skin and tissue-related signalling, and is one of the more popular three-peptide combinations within Australian peptide research. PhaseOne supplies the GLOW Blend to researchers across Australia as a high-purity lyophilised powder, independently HPLC verified at ≥98% purity per batch.
As a multi-peptide blend, GLOW does not have a single CAS number or molecular formula - each component peptide retains its own chemical identity within the vial. PhaseOne manufactures it to research-grade standards with full third-party testing, shipped Australia-wide. (!) Full Certificate of Analysis available for every batch view here.
GLOW combines GHK-Cu, BPC-157, and TB-500 in one vial. (!) Read about each individually: GHK-Cu, BPC-157, and TB-500.
Each peptide is studied for a distinct mechanism - GHK-Cu's copper-chelating and collagen-related signalling, BPC-157's gut and regenerative pathways, and TB-500's cellular migration research - making the blend of interest for researchers studying skin and tissue-related signalling together, and a combination frequently discussed within Australian peptide research communities.
The GLOW Blend should be stored refrigerated, unreconstituted, and protected from light, and is commonly reconstituted with bacteriostatic water prior to research use. (!) Read our reconstitution guide.
Every batch of the GLOW Blend sold across Australia is independently HPLC tested, with a Certificate of Analysis verifying all three peptide components.
GLOW contains three peptides, while our KLOW Blend adds a fourth component. (!) Compare with our KLOW Blend.
Disclaimer
All products supplied by PhaseOne are intended strictly for laboratory research purposes only. Products are not intended for human consumption, therapeutic use, cosmetic use, veterinary use, or diagnostic applications.
